Published in Surgery Litigation and Law Weekly, January 5th, 2007
This trend article about Hiroshima University, Japan, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Data detailed in "A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma" have been presented. According to recent research published in the journal Digestive Diseases and Sciences, "Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands have an antitumor effect. The aim of this study was to clarify whether...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.